-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EMDCx1Zgr7cYTEIBrwq9BkZXADxCX0MkgBFfGGwW0HqKZRJvX2q5GOwJn7RssULi dCyJLwk/8WLgEqD3Mzx0lQ== 0000950120-98-000054.txt : 19980218 0000950120-98-000054.hdr.sgml : 19980218 ACCESSION NUMBER: 0000950120-98-000054 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 19980213 SROS: NONE GROUP MEMBERS: GALEN ASSOCIATES GROUP MEMBERS: GALEN PARTNERS INTERNATIONAL, L.P. GROUP MEMBERS: GALEN PARTNERS L P GROUP MEMBERS: WILLIAM R. GRANT SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: OCULAR SCIENCES INC /DE/ CENTRAL INDEX KEY: 0000882484 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 942985696 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-52699 FILM NUMBER: 98539445 BUSINESS ADDRESS: STREET 1: 475 ECCLES AVE CITY: S SAN FRANCISCO STATE: CA ZIP: 94080 MAIL ADDRESS: STREET 1: 475 ECCLES AVE CITY: S SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: O S I CORP DATE OF NAME CHANGE: 19970506 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GALEN PARTNERS L P CENTRAL INDEX KEY: 0000841156 STANDARD INDUSTRIAL CLASSIFICATION: [] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 610 FIFTH AVE STREET 2: 5TH FL CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 2122184990 MAIL ADDRESS: STREET 1: 610 FIFTH AVE STREET 2: 5TH FL CITY: NEW YORK STATE: NY ZIP: 10020 SC 13G 1 SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ___)* OCULAR SCIENCES, INC. ----------------------------------------------------------------- (Name of Issuer) COMMON STOCK ----------------------------------------------------------------- (Title of Class of Securities) 675744 10 6 ------------------------------------- (CUSIP Number) Check the following box if a fee is being paid with this statement [ ]. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7). *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 14 pages SCHEDULE 13G CUSIP No. 675744 10 6 Page 2 of 14 Pages ------------- --- ---- --------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Galen Partners, L. P. --------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [ ] (B) [X] --------------------------------------------------------------------- 3 SEC USE ONLY --------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware --------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF 2,678,348 SHARES ----------------------------------------------------- 6 SHARED VOTING POWER BENEFICIALLY - 0 - OWNED BY ----------------------------------------------------- 7 SOLE DISPOSITIVE POWER EACH 2,678,348 REPORTING ----------------------------------------------------- 8 SHARED DISPOSITIVE POWER PERSON WITH - 0 - --------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,678,348 --------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [X] Excludes 11,010 shares held of record by Galen Associates and 5,004 shares subject to options that are exercisable by William R. Grant within 60 days of December 31, 1997. --------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 12.3% --------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN --------------------------------------------------------------------- SCHEDULE 13G CUSIP No. 675744 10 6 Page 3 of 14 Pages ------------- --- ---- --------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Galen Partners International, L. P. --------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [X] (B) [ ] --------------------------------------------------------------------- 3 SEC USE ONLY --------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware --------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF 275,711 SHARES ----------------------------------------------------- 6 SHARED VOTING POWER BENEFICIALLY - 0 - OWNED BY ----------------------------------------------------- 7 SOLE DISPOSITIVE POWER EACH 275,711 REPORTING ----------------------------------------------------- 8 SHARED DISPOSITIVE POWER PERSON WITH - 0 - --------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 275,711 --------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [X] Excludes 11,010 shares held of record by Galen Associates and 5,004 shares subject to options that are exercisable by William R. Grant within 60 days of December 31, 1997. --------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.3% --------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN --------------------------------------------------------------------- SCHEDULE 13G CUSIP No. 675744 10 6 Page 4 of 14 Pages ------------- --- ---- --------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Galen Associates --------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [ ] (B) [X] --------------------------------------------------------------------- 3 SEC USE ONLY --------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware --------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF 11,010 SHARES ----------------------------------------------------- 6 SHARED VOTING POWER BENEFICIALLY - 0 - OWNED BY ----------------------------------------------------- 7 SOLE DISPOSITIVE POWER EACH 11,010 REPORTING ----------------------------------------------------- 8 SHARED DISPOSITIVE POWER PERSON WITH - 0 - --------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 11,010 --------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [X] Excludes 5,004 shares subject to options that are exercisable by William R. Grant within 60 days of December 31, 1997. --------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) .1% --------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN --------------------------------------------------------------------- SCHEDULE 13G CUSIP No. 675744 10 6 Page 5 of 14 Pages ------------- --- ---- --------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON William R. Grant --------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [ ] (B) [X] --------------------------------------------------------------------- 3 SEC USE ONLY --------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A. --------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF - 0 - SHARES ----------------------------------------------------- 6 SHARED VOTING POWER BENEFICIALLY - 0 - OWNED BY ----------------------------------------------------- 7 SOLE DISPOSITIVE POWER EACH 5,004 shares subject to options that are REPORTING exercisable within 60 days of December 31, 1997. PERSON ----------------------------------------------------- 8 SHARED DISPOSITIVE POWER WITH - 0 - --------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,004 shares subject to options that are exercisable within 60 days of December 31, 1997 --------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] --------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) .1% --------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN --------------------------------------------------------------------- ITEM 1. ISSUER'S NAME AND ADDRESS OF PRINCIPAL EXECUTIVE ------------------------------------------------ OFFICES: ------- (a) Ocular Sciences, Inc. (b) 475 Eccles Avenue South San Francisco, CA 94080 ITEM 2. INFORMATION CONCERNING PERSON FILING: ------------------------------------ (a) Galen Partners, L.P. (b) 610 Fifth Avenue, 5th Floor Rockefeller Center New York, NY 10020 (c) Delaware (d) Common Stock (e) 675744 10 6 ITEM 3. STATUS OF PERSON FILING: ----------------------- Not applicable. ITEM 4. OWNERSHIP: --------- (a) 2,678,348 (b) 12.3% (c) (i) Sole power to vote or to direct vote: 2,678,348 shares (ii) Shared power to vote or to direct vote: 0 shares (iii) Sole power to dispose or to direct the disposition: 2,678,348 shares (iv) Shared power to dispose or to direct the disposition: 0 shares ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: -------------------------------------------- Not applicable. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ------------------------------------------------ ANOTHER PERSON: -------------- Not applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF SUBSIDIARY: ----------------------------------------------- Not applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF GROUP: ------------------------------------------ Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP: ------------------------------ Not applicable. ITEM 10. CERTIFICATION: ------------- Not applicable. Page 6 of 14 pages ITEM 1. ISSUER'S NAME AND ADDRESS OF PRINCIPAL EXECUTIVE ------------------------------------------------ OFFICES: ------- (a) Ocular Sciences, Inc. (b) 475 Eccles Avenue South San Francisco, CA 94080 ITEM 2. INFORMATION CONCERNING PERSON FILING: ------------------------------------ (a) Galen Partners International, L.P. (b) 610 Fifth Avenue, 5th Floor Rockefeller Center New York, NY 10020 (c) Delaware (d) Common Stock (e) 675744 10 6 ITEM 3. STATUS OF PERSON FILING: ----------------------- Not applicable. ITEM 4. OWNERSHIP: --------- (a) 275,711 (b) 1.3% (c) (i) Sole power to vote or to direct vote: 275,711 shares (ii) Shared power to vote or to direct vote: 0 shares (iii) Sole power to dispose or to direct the disposition: 275,711 shares (iv) Shared power to dispose or to direct the disposition: 0 shares ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: -------------------------------------------- Not applicable. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ------------------------------------------------ ANOTHER PERSON: -------------- Not applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF SUBSIDIARY: ----------------------------------------------- Not applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF GROUP: ------------------------------------------ Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP: ------------------------------ Not applicable. ITEM 10. CERTIFICATION: ------------- Not applicable. Page 7 of 14 pages ITEM 1. ISSUER'S NAME AND ADDRESS OF PRINCIPAL EXECUTIVE ------------------------------------------------ OFFICES: ------- (a) Ocular Sciences, Inc. (b) 475 Eccles Avenue South San Francisco, CA 94080 ITEM 2. INFORMATION CONCERNING PERSON FILING: ------------------------------------ (a) Galen Associates (b) 610 Fifth Avenue, 5th Floor Rockefeller Center New York, NY 10020 (c) Delaware (d) Common Stock (e) 675744 10 6 ITEM 3. STATUS OF PERSON FILING: ----------------------- Not applicable. ITEM 4. OWNERSHIP: --------- (a) 11,010 (b) .1% (c) (i) Sole power to vote or to direct vote: 11,010 shares (ii) Shared power to vote or to direct vote: 0 shares (iii) Sole power to dispose or to direct the disposition: 11,010 shares (iv) Shared power to dispose or to direct the disposition: 0 shares ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: -------------------------------------------- Not applicable. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ------------------------------------------------ ANOTHER PERSON: -------------- Not applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF SUBSIDIARY: ----------------------------------------------- Not applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF GROUP: ------------------------------------------ Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP: ------------------------------ Not applicable. ITEM 10. CERTIFICATION: ------------- Not applicable. Page 8 of 14 pages ITEM 1. ISSUER'S NAME AND ADDRESS OF PRINCIPAL EXECUTIVE ------------------------------------------------ OFFICES: ------- (a) Ocular Sciences, Inc. (b) 475 Eccles Avenue South San Francisco, CA 94080 ITEM 2. INFORMATION CONCERNING PERSON FILING: ------------------------------------ (a) William R. Grant (b) 610 Fifth Avenue, 5th Floor Rockefeller Center New York, NY 10020 (c) U.S.A. (d) Common Stock (e) 675744 10 6 ITEM 3. STATUS OF PERSON FILING: ----------------------- Not applicable. ITEM 4. OWNERSHIP: --------- (a) 0 (b) .1% (c) (i) Sole power to vote or to direct vote: 0 shares (ii) Shared power to vote or to direct vote: 0 shares (iii) Sole power to dispose or to direct the disposition: 5,004 shares subject to exercisable options (iv) Shared power to dispose or to direct the disposition: 0 shares ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: -------------------------------------------- Not applicable. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ------------------------------------------------ ANOTHER PERSON: -------------- Not applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF SUBSIDIARY: ----------------------------------------------- Not applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF GROUP: ------------------------------------------ Not Applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP: ------------------------------ Not applicable. ITEM 10. CERTIFICATION: ------------- Not applicable. Page 9 of 14 pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. 2/12/98 ----------------------------------- Date GALEN PARTNERS, L.P. By: BGW Partners, L.P. General Partner By: /s/ Bruce F. Wesson ------------------------------- Name: Bruce F. Wesson Title: General Partner GALEN PARTNERS INTERNATIONAL, L.P. By: BGW PARTNERS, L.P. General Partner By: /s/ Bruce F. Wesson -------------------------------- Name: Bruce F. Wesson Title: General Partner Page 10 of 14 pages GALEN ASSOCIATES By: WESSON ENTERPRISES, INC. General Partner By: /s/ Bruce F. Wesson -------------------------------- Name: Bruce F. Wesson Title: President /s/ William R. Grant ----------------------------------- William R. Grant Page 11 of 14 pages EXHIBIT INDEX Sequentially Exhibit Document Description Numbered Page ------- -------------------- -------------- A Agreement of Joint Filing 13 Page 12 of 14 pages EX-99 2 EXHIBIT A EXHIBIT A Agreement of Joint Filing Each of the undersigned hereby agrees that they are filing jointly pursuant to Rule 13d-1(f)(1) of the Securities Exchange Act of 1934, as amended, the Statement dated February 12, 1998, containing the information required by Schedule 13G, for the shares of Common Stock of Ocular Sciences, Inc. which are held of record by Galen Partners, L.P., Galen Partners International, L.P. and Galen Associates and beneficially owned by the undersigned. Each of the undersigned hereby expressly disclaims beneficial ownership of any of such shares as to which he or it does not have an actual pecuniary interest. DATED: February 12, 1998 GALEN PARTNERS, L.P. By: BGW PARTNERS, L.P. General Partner By: /s/ Bruce F. Wesson --------------------------- Name: Bruce F. Wesson Title: General Partner GALEN PARTNERS INTERNATIONAL, L.P. By: BGW PARTNERS, L.P. General Partner By: /s/ Bruce F. Wesson -------------------------------- Name: Bruce F. Wesson Title: General Partner Page 13 of 14 pages GALEN ASSOCIATES By: WESSON ENTERPRISES, INC. General Partner By: /s/ Bruce F. Wesson -------------------------------- Name: Bruce F. Wesson Title: President /s/ William R. Grant ----------------------------------- William R. Grant Page 14 of 14 pages -----END PRIVACY-ENHANCED MESSAGE-----